5-alpha-reductase inhibitors for lower urinary tract symptoms secondary to benign prostatic obstruction

Autor:	James Tacklind, Hugo Lopez, Herney Andrés García-Perdomo
Rok vydání:	2015
Předmět:	Quality of life medicine.medical_specialty Urology URINE RETENTION Steroid 5alpha reductase inhibitor Article chemistry.chemical_compound 5 Alpha-Reductase Inhibitor Disease association Urine retention Prostate disease Lower urinary tract symptoms Lower urinary tract symptom Medicine Clinical protocol Pharmacology (medical) Disease severity Priority journal business.industry Finasteride International prostate symptom score Dutasteride medicine.disease Drug effect Outcome assessment chemistry Systematic review Urogenital tract disease assessment International Prostate Symptom Score Benign prostatic obstruction Prostatic obstruction business Human
Zdroj:	The Cochrane Library Repositorio EdocUR-U. Rosario Universidad del Rosario instacron:Universidad del Rosario
ISSN:	1465-1858
DOI:	10.1002/14651858.cd011928
Popis:	This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effects of 5-alpha-reductase inhibitors (5ARIs) for treating lower urinary tract symptoms (LUTS) secondary to benign prostatic obstruction (BPO). © 2015 The Cochrane Collaboration.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::024ce1c6b2fb31e921ecf31f3b1b5cba https://doi.org/10.1002/14651858.cd011928 Zobrazit plný text záznamu